The interaction of FNDC5 (rs1746661) with known genetic risk factors for sporadic AD, such as ApoE-ε4 and triggering receptor expressed on myeloid cells 2, to predispose the brain to neurodegenerative changes should also be investigated. Here, FNDC5 is linked to Alzheimer disease.